Used in research to detect and study the Nav1.9 voltage-gated sodium channel, this antibody helps investigate pain signaling pathways, particularly in chronic and inflammatory pain conditions. It enables precise identification of Nav1.9 expression in sensory neurons, supporting drug development for pain management and neurological disorders. Commonly applied in immunohistochemistry, Western blotting, and flow cytometry to validate target engagement and tissue distribution in preclinical models.